U.S. NeuroSurgical Holdings Announces Material Agreement & Officer Changes
Ticker: EHSI · Form: 8-K · Filed: Jul 12, 2024 · CIK: 1089815
| Field | Detail |
|---|---|
| Company | U.S. Neurosurgical Holdings, Inc. (EHSI) |
| Form Type | 8-K |
| Filed Date | Jul 12, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.50, $2.8 million, $5,000,000 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, officer-changes, director-changes
Related Tickers: USNH
TL;DR
USNH inked a big deal & shuffled execs on July 10th.
AI Summary
U.S. NeuroSurgical Holdings, Inc. announced on July 10, 2024, a material definitive agreement and changes in its board and officer composition. The company also reported on compensatory arrangements for certain officers. Specific details regarding the material agreement and compensatory arrangements were not disclosed in this filing.
Why It Matters
This filing indicates significant corporate actions, including a new material agreement and potential changes in leadership or compensation structures, which could impact the company's future operations and investor outlook.
Risk Assessment
Risk Level: medium — The filing reports on a material definitive agreement and changes in officers, which can introduce uncertainty and potential risks related to the agreement's terms and leadership transitions.
Key Players & Entities
- U.S. NeuroSurgical Holdings, Inc. (company) — Registrant
- July 10, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by U.S. NeuroSurgical Holdings, Inc. on July 10, 2024?
The filing states that U.S. NeuroSurgical Holdings, Inc. entered into a material definitive agreement on July 10, 2024, but the specific details of this agreement are not disclosed in the provided text.
What changes were made regarding directors or officers of U.S. NeuroSurgical Holdings, Inc. on July 10, 2024?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as compensatory arrangements for certain officers, effective July 10, 2024.
What is the Commission File Number for U.S. NeuroSurgical Holdings, Inc.?
The Commission File Number for U.S. NeuroSurgical Holdings, Inc. is 000-26575.
What is the IRS Employer Identification Number for U.S. NeuroSurgical Holdings, Inc.?
The IRS Employer Identification Number for U.S. NeuroSurgical Holdings, Inc. is 52-1842411.
Where is U.S. NeuroSurgical Holdings, Inc. incorporated?
U.S. NeuroSurgical Holdings, Inc. is incorporated in Delaware.
Filing Stats: 839 words · 3 min read · ~3 pages · Grade level 9.6 · Accepted 2024-07-12 14:28:21
Key Financial Figures
- $0.50 — he Company's common stock at a price of $0.50 per share. To date, the Company has rai
- $2.8 million — as raised an aggregate of approximately $2.8 million. On July 10, 2024, the Board of Directo
- $5,000,000 m — of the private placement to raise up to $5,000,000 maximum. Item 5.02. Departure of Directo
Filing Documents
- usnu20240712_8k.htm (8-K) — 21KB
- 0001437749-24-022636.txt ( ) — 140KB
- usnu-20240710.xsd (EX-101.SCH) — 3KB
- usnu-20240710_def.xml (EX-101.DEF) — 10KB
- usnu-20240710_lab.xml (EX-101.LAB) — 14KB
- usnu-20240710_pre.xml (EX-101.PRE) — 10KB
- usnu20240712_8k_htm.xml (XML) — 2KB
01. Entry onto a Material Agreement
Item 1.01. Entry onto a Material Agreement. As previously reported, on January 16, 2024, U.S. NeuroSurgical Holdings, Inc., a Delaware corporation, ("Company") held an initial closing of a private placement of shares of the Company's common stock at a price of $0.50 per share. To date, the Company has raised an aggregate of approximately $2.8 million. On July 10, 2024, the Board of Directors of the Company (the "Board") approved amending the terms of the private placement to raise up to $5,000,000 maximum. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Director and Officer and Election of Director and Officer Appointment Effective July 10, 2024, Mr. Charles H. Merriman resigned from his position as a member of the Board and from all of its committees. Mr. Merriman's resignation was not the result of any disagreement between the Company and him on any matter relating to the Company's operations, policies or practices. On July 10, 2024, Mr. Alan Gold resigned from his positions as President of the Company, effective immediately. Mr. Gold continues to serve as a member of the Board, but as of the effective date no longer serves as the Chairman of the Board. Also on July 10, 2024, the Board unanimously appointed Dr. Prasad A. Jeereddi, age 76, Chief Executive Officer of the Company and also appointed Dr. Jeereddi as a non-executive director and Chairman of the Company's Board, effective immediately. As disclosed in the Company's Form 10-K for its fiscal year ended December 31, 2023, Dr. Jeereddi has been a key participant in the development of the business of the Company's Elite Health Plan, Inc. subsidiary and is also the beneficial owner of approximately 1.5 million shares of the Company's Common Stock. Dr. Jeereddi, affiliated with Pomona Valley Hospital Medical Center and San Antonio Regional Hospital, is a doctor of internal medicine
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 12, 2024 U.S. NeuroSurgical Holdings, Inc. By: /s/ Dr. Prasad A. Jeereddi Name: Dr. Prasad A. Jeereddi Title: Chief Executive Officer 3